Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Transaction Advisory

Skip to the end of the Expertise Menu

IGeneX-2BOSTON, MA – Balance Point Capital Partners, L.P. (BPCP) and 4C Capital (4C) have made an investment in IGeneX, Inc. (IGeneX). IGeneX is a CLIA certified reference laboratory providing molecular and immunological testing services for Lyme and associated tick-borne diseases to private practice physicians, hospitals, and other clinical reference laboratories worldwide. The Company is committed to providing innovative, state-of-the-art clinical testing. Dr. Jyostna Shah, former Vice President and Laboratory Director of IGeneX, will become the CEO of the Company. Provident Healthcare Partners served as the exclusive financial advisor to IGeneX. The terms of the transaction were not disclosed.

“I am very excited about the partnership with Balance Point. I am looking forward to working with my new partners to help facilitate and support our R&D and growth efforts,” said Dr. Jyotsna Shah, IGeneX’s CEO. Justin Kaplan, a Partner with Balance Point adds, “We are very proud to make an investment in IGeneX and support Dr. Shah and her team. We welcome the opportunity to work with a leader in Lyme disease testing and look forward to assisting IGeneX in advancing its core mission of providing testing services for tick borne diseases.”

Commenting on Provident Healthcare’s services, Advisor to IgeneX Bernard Weinzimmer commented, “I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done this without Provident’s leadership”.

“IGeneX is a true leader in its industry, and through this partnership with Balance Point, it will have the additional capital needed to continue expanding,” commented Dustin Thompson, Associate at Provident Healthcare Partners.

“IGeneX has long been a market leader within Lyme disease testing. IGeneX’s outstanding customer service and clinical expertise will be highly valued assets as Balance Point continues to build upon its platform,” noted Justin Hand, Managing Director at Provident Healthcare Partners.

About IGeneX
IGeneX is a high complexity, CLIA-certified clinical reference laboratory. The Company has been testing clinical samples for over 23 years. Its offerings include molecular and/or immunological tests for Lyme disease, Babesiosis, Ehrlichiosis, Bartonellosis, Rickettsiosis, and Chlamydia pneumonia. IGeneX offers several tests that are either not performed anywhere else in the world or are performed in a distinct manner that heighten sensitivity without losing specificity. For more information on IGeneX, please visit

About Balance Point
Balance Point Capital Partners is the successor fund to the First New England Capital (FNEC) family of funds. Founded in 1988, FNEC made over 75 investments in lower middle market companies through three distinct investment vehicles. Founded in 2011, BPCP represents the firm’s fourth investment fund dedicated to making investments in the lower middle market. BPCP targets high quality, lower middle market businesses with a history of cash flow stability. For more information on BPCP, please visit

About 4C Capital
4C Capital is a private investment and corporate holding firm that makes investments in companies for long term growth. 4C delivers Capital Capacity, Competitiveness, and Commitment that aligns with management’s vision to drive the next level of enterprise value. 4C leverages its operational expertise, investment sources and network of business opportunity contacts to strengthen and grow the lower middle market companies in which it invests. For more information on 4C, please visit

About Provident Healthcare Partners
Provident is the leading investment banking firm specializing in merger and acquisition advisory, strategic planning, and capital formation for middle market and emerging growth healthcare companies. The firm has a vast network of high-level, senior industry contacts, a thorough knowledge of market sectors and specialties, and unsurpassed experience and insight into the M&A process. Provident uncovers value and opportunities that others often overlook to create transaction premiums for its clients. For more information visit the Provident website

Contact: Provident Healthcare Partners
Boston, MA
Gina Leone, Senior Analyst


[holo_button icon=”” link=”/wp-content/uploads/2015/09/Igenex-Press-Release.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]